Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
About us

Response to emerging infections

COVID-19

Novel coronavirus
WHO
© Credits
17 February 2021

Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic

Zika virus

Emergency - Zika virus
WHO
© Credits
11 September 2025

Epidemic Intelligence from Open Sources (EIOS) Strategy 2024—2026